Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A

计划入组 16 人 · 首次发布于 2009 年 12 月 7 日

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A

计划入组 165 人 · 首次发布于 2010 年 8 月 13 日

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

计划入组 19 人 · 首次发布于 2014 年 3 月 11 日

Recombinant human coagulation factor VIII-Fc fusion protein(Haimen Gensciences)

Recombinant human coagulation factor VIII-Fc fusion protein(Chengdu Rongsheng )

Recombinant FVIII-Fc fusion protein (Chengdu Rongsheng)

Protein Sciences Corporation

United States

FUSION PHARMACEUTICALS

Nepal

Biomea Fusion

United States

Systematic Review Reveals Emicizumab Cost-Effectiveness Varies by Patient Population and Comparator in Hemophilia A Treatment

Sobi Showcases Efanesoctocog Alfa Data from XTEND Phase 3 Program at WFH 2025 Summit

FDA Clears HanchorBio's HCB101 Single-Patient Expanded Access Protocol, a First for SIRPα-Fc Fusion Proteins